Literature DB >> 16927388

Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.

Masato Goya1, Genichiro Ishii, Shinichi Miyamoto, Takahiro Hasebe, Kanji Nagai, Hiroyuki Yonou, Tadashi Hatano, Yoshihide Ogawa, Atsushi Ochiai.   

Abstract

BACKGROUND: Prostate cancer is frequently associated with bone metastases with marked osteoblastic changes and low osteoclastic activity but its mechanism is not well understood. We previously reported that prostate-specific antigen (PSA) stimulated the proliferation and the activation of osteoblasts. In this study, we investigated the effect of PSA on osteoclastogenesis.
METHODS: Two human prostate cancer cell lines and PSA were directly injected into human adult bone (HAB) implanted into NOD/SCID mice, followed by morphological analysis. RAW 264.7 cells, murine osteoclast precursor, were treated with PSA.
RESULTS: PSA-producing LNCaP and PSA caused a significant decrease of osteoclast precursors and osteoclasts in HAB accompanied by osteoblast proliferation and new bone formation, while PSA-nonproducing PC3 showed increasing osteoclasts with osteolysis. PSA induced apoptosis of RAW 264.7 cells in vitro. PSA-induced apoptosis was dependent of enzymatic activity of PSA and was specific to immature tartrate-resistant acid phosphatase-negative mononuclear RAW 264.7 cells.
CONCLUSIONS: PSA plays a crucial role for osteoblastic bone metastasis by promoting both osteoblasts proliferation and apoptosis of osteoclast precursors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927388     DOI: 10.1002/pros.20375

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  9 in total

Review 1.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

2.  Trypsin-like proteolytic contamination of commercially available psa purified from human seminal fluid.

Authors:  Michael L Manning; Maya Kostova; Simon A Williams; Samuel R Denmeade
Journal:  Prostate       Date:  2011-12-28       Impact factor: 4.104

3.  Clinical features and prognostic factors for patients with bone metastases from prostate cancer.

Authors:  Jian He; Zhao-Chong Zeng; Ping Yang; Bing Chen; We Jiang; Shi-Suo Du
Journal:  Asian J Androl       Date:  2012-04-16       Impact factor: 3.285

4.  Blockade of transforming growth factor-beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line.

Authors:  Sweta Mishra; Yuping Tang; Long Wang; Linda deGraffenried; I-Tien Yeh; Sherry Werner; Dean Troyer; John A Copland; Lu-Zhe Sun
Journal:  Prostate       Date:  2011-02-14       Impact factor: 4.104

5.  Urologic skeletal metastases: current diagnostic and treatment strategies.

Authors:  Stephanie H Alford; Paul S Chang; Ronald P Williams
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

6.  The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.

Authors:  Mohsen Beheshti; Reza Vali; Peter Waldenberger; Friedrich Fitz; Michael Nader; Josef Hammer; Wolfgang Loidl; Christian Pirich; Ignac Fogelman; Werner Langsteger
Journal:  Mol Imaging Biol       Date:  2009 Nov-Dec       Impact factor: 3.488

7.  The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.

Authors:  Mohsen Beheshti; Reza Vali; Peter Waldenberger; Friedrich Fitz; Michael Nader; Josef Hammer; Wolfgang Loidl; Christian Pirich; Ignac Fogelman; Werner Langsteger
Journal:  Mol Imaging Biol       Date:  2009-07-09       Impact factor: 3.488

8.  Complex dynamics of osteoclast formation and death in long-term cultures.

Authors:  Timur Akchurin; Tayeb Aissiou; Naomi Kemeny; Erin Prosk; Nilima Nigam; Svetlana V Komarova
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

Review 9.  The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.

Authors:  Sathana Dushyanthen; Davina A F Cossigny; Gerald M Y Quan
Journal:  Cancer Growth Metastasis       Date:  2013-11-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.